Skip to content

Clinical trials

Phase 1 Rectal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 1 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20141
20171
20221
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Academy of Medical Sciences2
Chongqing Precision Biotech Co., Ltd2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1
Fudan University1
Huashan Hospital1
Novartis Pharmaceuticals1
UTC Therapeutics Inc.1
Zhejiang Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms11
Lung Neoplasms4
Colonic Neoplasms3
Esophageal Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Colorectal Neoplasms2
Stomach Neoplasms2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.